Tamiflu Strategy May Walk Fine Line

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

It’s hard to escape the daily barrage of bird flu mentions in the media these days, culminating with last week’s ABC TV movie Fatal Contact: Bird Flu in America, a worst-case dramatization of the pandemic hitting the U.S.

In the coming months, Hoffmann- La Roche will take on the issue as it advertises its prescription drug Tamiflu, which is one of only a handful of drugs proven effective against bird flu.

The Nutley, N.J., client this week is expected to award its $30 million account to independent GSW in Columbus, Ohio, after a review that included Publicis Groupe’s The Kaplan Thaler Group, Interpublic Group’s Foote Cone & Belding, and independent shops Avenue A/Razorfish and Digitas, all New York, sources said.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in